Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-13T20:53:06.898Z Has data issue: false hasContentIssue false

Chaperonin-mediated protein folding: using a central cavity to kinetically assist polypeptide chain folding

Published online by Cambridge University Press:  29 July 2009

Arthur L. Horwich*
Affiliation:
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USADepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA
Wayne A. Fenton
Affiliation:
Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA
*
*Author for correspondence: Dr. A. L. Horwich, Howard Hughes Medical Institute, Yale University School of Medicine, Boyer Center, 295 Congress Avenue, New Haven, CT 06510, USA. Tel.: 203-737-4431; Fax: 203-737-1761; Email: arthur.horwich@yale.edu
Rights & Permissions [Opens in a new window]

Abstract

The chaperonin ring assembly GroEL provides kinetic assistance to protein folding in the cell by binding non-native protein in the hydrophobic central cavity of an open ring and subsequently, upon binding ATP and the co-chaperonin GroES to the same ring, releasing polypeptide into a now hydrophilic encapsulated cavity where productive folding occurs in isolation. The fate of polypeptide during binding, encapsulation, and folding in the chamber has been the subject of recent experimental studies and is reviewed and considered here. We conclude that GroEL, in general, behaves passively with respect to its substrate proteins during these steps. While binding appears to be able to rescue non-native polypeptides from kinetic traps, such rescue is most likely exerted at the level of maximizing hydrophobic contact, effecting alteration of the topology of weakly structured states. Encapsulation does not appear to involve ‘forced unfolding’, and if anything, polypeptide topology is compacted during this step. Finally, chamber-mediated folding appears to resemble folding in solution, except that major kinetic complications of multimolecular association are prevented.

Information

Type
Review Article
Copyright
Copyright © Cambridge University Press 2009
Figure 0

Fig. 1.Architecture of the GroEL–GroES chaperonin complex, based on the GroEL–GroES–ADP7 crystallographic model (PDB 1AON; Xu et al.1997). (a) Cut-away view of a space-filling model of the GroEL–GroES complex, with hydrophobic side chains colored yellow and hydrophilic ones blue. Note the relative hydrophobicity of the trans, polypeptide-accepting ring, and hydrophilicity of the cis folding chamber formed by GroES binding to a GroEL ring. (b) Ribbon diagram of GroEL–GroES with the individual domains of one subunit in the upper, cis ring colored red (apical), green (intermediate), and blue (equatorial). (c) Same view as in (b), except each subunit in the cis ring is in a different color and GroES is colored yellow. (d) View of the complex from the top, looking down on GroEL, colored as in (c). Note that the apparent ‘hole’ down the long axis of the complex reflects that the flexible C-terminal tails of each GroEL subunit, lying in the equatorial regions of the central cavity of each ring, are not resolved in the crystal structure. Figure modified from Horwich et al. (2006), with permission. Copyright 2006, American Chemical Society.

Figure 1

Fig. 2.The polypeptide folding cycle at GroEL. (a) The initial polypeptide acceptor state in vivo and in a cycling reaction in vitro is an asymmetric, ADP-containing complex, as shown in Fig. 1 (Rye et al.1997; Xu et al.1997). (b) ATP and non-native polypeptide (green) bind rapidly to the open ring of the ADP asymmetric complex, with ATP producing downward rigid body movement of the intermediate domain via contacts with the nucleotide pocket (Chaudhry et al.2003) and attendant small elevation and counterclockwise twist of the apical domains (Ranson et al.2001), the latter of which directly enable GroES binding. ATP binding also sends an allosteric signal to the opposite (trans) ring that ejects its ligands: GroES, substrate polypeptide, and ADP (Rye et al.1997). The binding of non-native polypeptide along with ATP accelerates such departure of GroES (Rye et al.1999). (c) Initial GroES interaction with the ATP–polypeptide-bound ring, occurring by ~0·2 s (Cliff et al.2006), is followed over ~0·8 s by large and forceful rigid body elevation and clockwise twisting movements (60° and 120°, respectively) that eject polypeptide into a GroES-encapsulated hydrophilic chamber where polypeptide attempts to fold (Weissman et al.1996; Xu et al.1997; Rye et al.1997). This folding-active cis complex is the longest-lived state in the folding cycle. (d) ATP hydrolysis, occurring with a half-time of ~10 s, primes the cis complex for discharge of its ligands by weakening affinity of GroEL for GroES (Rye et al.1997). (e) ATP hydrolysis gates the binding of ATP and non-native polypeptide to the trans ring (Rye et al.1999), a function of allosteric behavior. In the case of ATP, such behavior is anti-cooperative between rings (sequential, KNF) and positive (concerted, MWC) within the rings, overall a ‘nested’ behavior (Yifrach & Horovitz, 1995). ATP (and polypeptide) binding to the trans ring discharges GroES and polypeptide from the old cis ring and leads to a new round of cis encapsulation and folding in this (opposite) ring. Note that the 10 s or so of folding time in the cis complex is not sufficient for most molecules of stringent, GroEL–GroES-dependent substrate proteins to fold to native form; typically, only a few percent reach the native state. The other molecules are discharged at (e) in non-native states that, in vitro, are rebound by other GroEL complexes for another attempt at folding. In the cell, such non-native forms can also partition to other chaperones or the degradative apparatus, their fate depending on the relative concentrations and affinities of the various components. D indicates ADP, T indicates ATP.

Figure 2

Fig. 3.The apical residues that form the hydrophobic binding surface of a GroEL subunit. A ribbons model is shown, with side chains of residues whose mutation abolishes polypeptide binding shown as yellow sticks and labeled with residue numbers. The residues are grouped on three structures – helix H, helix I, and an underlying extended segment – from top to bottom, respectively. (a) View en face from inside the central cavity. (b) View from one side of a subunit, with the cavity to the left. From Horwich et al. (2006), with permission. Copyright 2006, American Chemical Society.

Figure 3

Fig. 4.Topologies of non-native MDH bound to GroEL. Three image classes from a cryo-EM reconstruction (Elad et al.2007) are illustrated in side and end views. (a, d, g) Sections through the MDH-bound GroEL subunits in each class, showing the fitting of the GroEL apical domain secondary structural elements. Note the areas at the end of each domain without fitted elements, with density contributed by the bound non-native MDH. (b, e, h) Side views of a substrate-bound subunit (see thumbnail at top), with the GroEL rendered as a surface at 14 Å and the difference density corresponding to MDH colored yellow, green, or blue. (c, f, i) Top views of substrate-bound subunits (see thumbnail) rendered as in (b, e, h). Three GroEL subunits are shown in (c) and (f) and four in (i), corresponding to the number of subunits contacted by substrate in each of these classes. (j) The individual difference densities corresponding to MDH for each class, compared with the surface representation of an MDH subunit monomer (red) filtered to 20 Å; the exposed dimer interface of the MDH subunit in the bottom image is colored purple. Modified from Elad et al. (2007), with permission. Copyright 2007, Elsevier.

Figure 4

Fig. 5.Topologies of three peptides bound to the apical domain of GroEL. The backbones of the GroES mobile loop segment (blue) (Xu et al.1997), the ‘strong binding peptide’ (green) of Chen & Sigler (1999), and the N-terminal extension peptide from Buckle et al.1997 (magenta) are shown overlaid on aligned Cα ribbon trace of apical domain helices H and I of GroEL (red) from the respective structures. Note that the bound regions of all three peptides appear to occupy nearly the same position in the groove between the two helices. From Fenton & Horwich (2003), with permission. Copyright 2003, Cambridge University Press.

Figure 5

Fig. 6.Tryptophan fluorescence of human DHFR refolding from urea. At the times indicated, an excess of GroEL was added. The solid triangles show the entire time-course of refolding in the absence of chaperonin. Note that addition of GroEL apparently stops the refolding of DHFR whenever it is added to the ongoing solution reaction, implying that GroEL can recruit the ensemble of non-native intermediates present throughout the course of the folding reaction. Redrawn from Goldberg et al.1997. Copyright 1997, National Academy of Sciences, USA.

Figure 6

Fig. 7.‘Stretching’ of non-native Rubisco upon binding to GroEL, as monitored by changes in FRET. (a) Schematic of the experiment. A kinetically trapped, apparently misfolded monomer of Rubisco (able to be converted to the native state by addition of GroEL–GroES–ATP), labeled near its N- and C-termini with the FRET pair AEDANS and fluorescein, was stable at 4°C and showed an interprobe distance of ~37 Å. After binding to GroEL (or SR1) to form a binary complex, the interprobe distance increased to >70 Å for the GroEL complex and to 46–47 Å for the SR1 complex. This indicates a significant stretching of Rubisco as a result of binding to the apical domains. (b) Stopped-flow experiment to determine the rate at which stretching occurs. The changes in FRET efficiency for Rubisco binding to both GroEL and SR1 were biphasic, requiring two exponential terms for fitting. Only the faster rate was dependent on chaperonin concentration, and the bimolecular rate constant with GroEL, 2×105 to 4×105 M−1 s−1, was essentially equal to the independently measured rate constant for Rubisco binding to GroEL under these conditions. This suggests that the stretching occurring during the faster step is an inherent feature of Rubisco binding. Redrawn from Lin & Rye (2004), with permission. Copyright 2004, Elsevier.

Figure 7

Fig. 8.Folding of Rubisco by GroEL added at different times after dilution from denaturant. Acid-denatured Rubisco was diluted directly into refolding buffer containing GroEL, GroES, and ATP (squares) or into buffer with GroES and ATP, with GroEL added at 15 (triangles) or 30 min (circles). In each case, the rate of recovery of Rubisco activity was the same, although the yield decreased with time before GroEL addition. In the absence of added GroEL, however, no Rubisco activity was recovered. This suggests that GroEL is binding a metastable, kinetically trapped intermediate and returning it to a folding pathway. Redrawn from Todd et al. (1996), with permission. Copyright 1996, National Academy of Sciences, USA.

Figure 8

Fig. 9.Motions of a GroEL subunit on binding ATP and GroES. One subunit of GroEL, oriented as indicated in the thumbnail on the upper left, is shown in a set of Cα traces based on the crystal structure 1GRL (left; Braig et al.1994), EM structure 1GR6 (middle; Ranson et al.2001), and crystal structure 1AON (right; Xu et al.1997). When ATP (gold) binds to the equatorial domain (blue) (middle), small changes in the intermediate domain (green) lead to a slight elevation and 20° counterclockwise twist of the apical domain (red). Subsequent GroES (gray) binding (right) produces a much larger additional elevation (50°) of the apical domain, accompanied by a 120° clockwise twist that removes the apical polypeptide binding site from facing the cavity and permits GroES to bind stably to the apical domain via its mobile loop. The forceful movement of the apical domains driven during the second step releases polypeptide into the chamber to begin folding.

Figure 9

Fig. 10.Timeline of formation of a cis folding-active complex. The formation of a cis GroEL–GroES–ATP–polypeptide complex is diagrammed based on the phases and their rates of formation as reported by Cliff et al. (2006). Only one GroEL ring is shown for simplicity. First, an unliganded ring (T state) rapidly binds ATP to form the R1:ATP state with somewhat twisted apical domains (cf. Fig. 9, middle). If non-native polypeptide is present, it likely binds to this state after ATP binds. GroES then interacts (with or without polypeptide) to form the R2:ATP state, essentially a collision complex where GroES and polypeptide share the apical binding sites, which are still exposed in the cavity. In a somewhat slower step, the R2:ATP state converts to the R3:ATP:GroES state, during which large rigid body apical domain movements occur (see second step of Fig. 9), releasing polypeptide into the central chamber to fold.

Figure 10

Fig. 11.Polypeptide acts as a load on the apical domains, restricting their rate of movement when ADP and GroES are added. (a) Ribbons representations of a subunit of unliganded GroEL (top) and a subunit of the cis ring of a GroEL–GroES–ADP–AlFx complex (bottom), colored as in Fig. 10 (note that GroES is not shown in the bottom panel). The thumbnails at the left show the position of the subunits in the intact complexes. Indicated are the two Cys residues that were labeled with a FRET reporter pair, fluorescein and tetramethylrhodamine, to monitor movements of the apical domain relative to the equatorial domain; the distances shown were measured between the β-carbons of these residues in the crystal structure (Chaudhry et al.2003). (b) Stopped-flow measurements of FRET changes on addition of GroES and ATP to GroEL–rhodanese or SR1–rhodanese complexes (left) or on addition of GroES and ADP (right). Gray traces show FRET changes of the respective chaperonins in the absence of substrate protein. The rates of change in FRET (with presence of polypeptide) were fit to the sum of two exponentials, as indicated in the individual panels. ATP supports a rapid movement of the apical domains even with polypeptide bound, with half-times (1–2 s) that are physiologically reasonable, given the ~10-s lifetime of the folding-active complex. With ADP, however, the rates are at least 20-fold slower (when substrate protein is present) and the extent of movement is reduced. When AlFx is added to the ADP complexes to form a folding-active ATP analog in the nucleotide binding site (right), the expected extent of the FRET change is achieved at a rate consistent with the refolding rate under these conditions. From Motojima et al. (2004). Copyright 2004, National Academy of Sciences, USA.

Figure 11

Fig. 12.The electrostatic and hydrophilic nature of the cis folding chamber. A cutaway view of a space-filling model of the cis chamber of a GroEL–GroES complex (1AON), with residues colored according to their nature: acidic (red), basic (blue), neutral polar (green), hydrophobic (yellow), and main chain (white). Parts of three subunits are shown. Y71 near the top is a GroES residue. Adapted from Farr et al. (2007), with permission. Copyright 2007, National Academy of Sciences, USA.

Figure 12

Fig. 13.Folding in the GroEL–GroES chamber vs. folding in solution. (a) An unfolded polypeptide substrate (U), released from the hydrophobic apical binding sites upon ATP–GroES addition, folds in isolation in the cis chamber to produce native protein, with no possibility that aggregation can intervene, and at a rate that is essentially the intrinsic folding rate of the polypeptide. (b) A non-native polypeptide diluted from denaturant into solution can fold to the native state or it can undergo aggregation, often in a stepwise manner with low-order aggregates forming initially. If this initial aggregation step is reversible, the overall rate of folding to the native state will be reduced relative to the intrinsic rate, although the yield may not be affected. Irreversible aggregation, by contrast, will not affect the rate of renaturation but will reduce the yield. Folding in the chaperonin chamber avoids these complications on the folding landscape by preventing aggregation altogether.